SHULMAN JOSEPH (Chief Technical Officer) sold 24.2% of their position (5.08K shares) of RHYTHM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $608.2K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/17/2026ACC: 0001649904-26-000015
Officer· Chief Technical Officer
Since Feb 2022
-5.08K
Net shares
Net seller
$608.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
2.02K acquired · 7.10K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.02K
Price / share
$6.80
Trade value
$13.76K
% of position
10.7%
8/13/2026
18.97K→20.99K
Common Stock
Direct
Shares
−5.08K
Price / share
$119.75
Trade value
$608.21K
% of position
24.2%
8/13/2026
20.99K→15.91K
Total
Net shares
−3.06K
Net value
-$594.45K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/13/2026 | M · Option Exercise | +2.02K | $6.80 | $13.76K | 10.7% | 18.97K | 20.99K |
| Common Stock Direct | 8/13/2026 | S · Sale | −5.08K | $119.75 | $608.21K | 24.2% | 20.99K | 15.91K |
| Total | −3.06K | -$594.45K | ||||||
Derivative Transactions1
Stock Options (Right to Buy)
Direct
Converts to
Common Stock
2.02K shares
Shares
−2.02K
Strike price
6.80
Held after
5.95K
Exercisable
—
8/13/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) Direct | Common Stock2.02K shares | 8/13/2026 | M · Option Exercise | −2.02K | 6.80 | — | 5.95K |